Cargando…
Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
Alzheimer's disease (AD) is the most common form of dementia caused by neurodegenerative process and is tightly related to amyloid β (Aβ) and neurofibrillary tangles. The lack of early diagnostic biomarker and therapeutic remedy hinders the prevention of increasing population of AD patients eve...
Autores principales: | Han, Sun-Ho, Mook-Jung, Inhee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101776/ https://www.ncbi.nlm.nih.gov/pubmed/25045220 http://dx.doi.org/10.3346/jkms.2014.29.7.893 |
Ejemplares similares
-
Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review
por: Park, Jong-Chan, et al.
Publicado: (2020) -
The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease
por: Kim, Dong Kyu, et al.
Publicado: (2019) -
Special issue on neurodegenerative diseases and their therapeutic approaches
por: Kim, Jungsu, et al.
Publicado: (2015) -
Disruption of blood-brain barrier in Alzheimer disease pathogenesis
por: Kook, Sun-Young, et al.
Publicado: (2013) -
Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease
por: Kang, You Jung, et al.
Publicado: (2020)